Skip to content

USANA Health Sciences USNA Inventory write-downs

Inventory write-downs at other companies

Herbalife logo
HerbalifeHLF
$5.9M-48.2%
Universal Corporation logo
Universal CorporationUVV
$34.66M+164%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's inventory write-downs?
USANA Health Sciences (USNA) reported inventory write-downs of $1.3M in Q1 2026.
How has USANA Health Sciences's inventory write-downs changed year-over-year?
USANA Health Sciences's inventory write-downs increased by 7.3% year-over-year, from $1.21M to $1.3M.
What is the long-term trend for USANA Health Sciences's inventory write-downs?
Over 3 years (2021 to 2025), USANA Health Sciences's inventory write-downs has grown at a -13.9% compound annual growth rate (CAGR), from $4.2M to $2.68M.
What does inventory write-downs mean?
This represents the non-cash expense recognized when the carrying value of inventory is reduced due to obsolescence, damage, or market value decline. It serves as an indicator of inventory management efficiency and potential product lifecycle risks within the supply chain.